Howard University Telehealth Training Center
HUTTC Home | About | News | Current Projects | Past Projects | On-Demand Videos and Podcasts

5. Culturally Competent Care for Substance Users Diagnosed with HIV Disease

Concerns Regarding Effects of Substance Use on HAART Adherence

Clinicians have typically been hesitant to initiate HAART in substance users, due to the belief that the multiple social, medical, and economic challenges faced by substance users could mean that they are less likely to be able to adhere to their treatment regimens, thereby risking non-suppression of viral replication and development of HIV drug resistance. [Lert 2007] More recently, however, Wood and colleagues
have shown that, after adjusting for adherence, HIV-infected injection
drug users and nonusers who receive HAART have comparable 5-year survival rates. [Wood 2008]

Findings like these underline the importance of the development and provision of comprehensive treatment programs that address both substance use and HIV disease at the same time. Previously, Wood and colleagues had reported that, even in areas where more aggressive provision of HAART for substance users is preferred, both IDUs and non-IDUs showed similar rates of resistance to all of the major classes of antiretrovirals after 30 months of follow-up. Findings such as this may help to alleviate concerns that prescribing HAART to substance users risks the development of higher rates of antiretroviral resistance. [Wood 2005]

Adherence to HAART is a critical determinant of patients’ clinical and virologic outcomes, and inadequate adherence is associated with poorer outcomes in HIV-positive patients who are also substance users. [Tuboi 2005, Knobel 2001, Arnsten 2002] A variety of studies has shown that ongoing substance use by patients receiving HAART is strongly correlated with poor adherence and reduced treatment efficacy. For example, one analysis reported 27% adherence rates and 13% of subjects achieving undetectable HIV-1 RNA in patients reporting current cocaine abuse and 68% adherence rates and 46% of subjects achieving undetectable HIV-1 RNA in patients reporting no cocaine abuse. [Arnsten 2002] However, ongoing substance users who are adherent to HAART have been shown to achieve rates of virologic suppression comparable to those of non-substance users. [Wood 2003, Wood 2004]

Results such as these imply that the poorer virologic and clinical outcomes often reported among HIV-positive substance abusers are due primarily to delayed access to therapy and poor adherence once therapy is begun. In the era before the widespread use of HAART, there were limited differences in outcomes between substance users and non-substance users because the available treatments were much less effective than those available today. The introduction of HAART, however, significantly increased the importance of adherence, and inadequate adherence among substance users currently is associated with greater risk for HIV-related morbidity and mortality in this population. [Celentano 2007]

« BACK

NEXT »